FundedIQ
Biotechnology

VivoSim Labs: Funding, Investors & Team (Sep 2026)

Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.

vivosim.ai LinkedIn San Diego, United States 51-100 employees
Biotechnology Medical Therapeutics
Total raised
$4.0M
Rounds
1
Latest
Undisclosed round
Apr 2026

VivoSim Labs has raised $4.0M across 1 funding round on record, the most recent an undisclosed round of $4.0M announced in Apr 2026.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

VivoSim Labs Company Profile and Key Stats

Total funding raised
$4.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$4.0M in Apr 2026
Employees
51-100
reported band
Headquarters
San Diego, United States

Latest funding round on record: Apr 2026.

VivoSim Labs Funding Rounds

Date
Round
Amount
Undisclosed round
$4.0M

VivoSim Labs Founders and Leadership Team

Name
Role
Contact
Keith Murphy
Founder

No contact details are on record for this team yet.

VivoSim Labs Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M

VivoSim Labs' latest round of $4.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like VivoSim Labs in Biotechnology and San Diego

Companies Similar to VivoSim Labs

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

VivoSim Labs Funding FAQs

What does VivoSim Labs do?

Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.

How much funding has VivoSim Labs raised?

VivoSim Labs has raised $4.0M across 1 round on record. The most recent is an undisclosed round of $4.0M announced in Apr 2026.

When did VivoSim Labs last raise funding?

VivoSim Labs' most recent funding round on record is an undisclosed round of $4.0M, announced in Apr 2026.

Who founded VivoSim Labs?

FundedIQ lists Keith Murphy (Founder) at VivoSim Labs.

Where is VivoSim Labs headquartered?

VivoSim Labs is based in San Diego, California, United States.

How many employees does VivoSim Labs have?

VivoSim Labs is in the 51-100 employee band.

How does VivoSim Labs' funding compare to other Biotechnology startups?

VivoSim Labs' latest round of $4.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's VivoSim Labs Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VivoSim Labs is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.